Company Profile on AtriCure, Inc.

AtriCure, Inc., a medical device company, engages in the development, manufacture, and sale of cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac tissue. It offers AtriCure Isolator, which consists of an ablation and sensing unit, a compact power generator that delivers bipolar radio-frequency energy; AtriCure switch box, a compact switch box, which provides the technology needed for the dual pulsing electrodes, and ability to connect and toggle between multiple devices, including clamps and multifunctional pen; and Isolator Synergy Bipolar Radio-Frequency Ablation Clamps for open-heart procedures and minimally invasive procedures. The company also provides multifunctional bipolar pen, which enables surgeons to toggle back and forth between temporary pacing, sensing, stimulation, and ablation; and Coolrail linear ablation device, which is designed to allow the physician to create an expanded cardiac ablation lesion set during minimally invasive procedures. In addition, it offers Lumitip dissector to separate tissues to provide access to key anatomical structures that are targeted for ablation during general, thoracic, and other surgical procedures; AtriCure Left Atrial Appendage Exclusion System that is designed to exclude the left atrial appendage; Frigitronics CCS-200 product line for cardiac ablation; and Cryo1, a disposable cryothermy ablation probe. The company sells its products to hospitals and medical centers primarily through its direct sales force in the United States, as well as through distributors in Europe, Asia, South America, and Canada. AtriCure is headquartered in West Chester, Ohio.